Compare Aurora Cannabis Inc (ACB) vs Ishares Msci Brazil ETF (EWZ) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

EWZ, the iShares MSCI Brazil ETF, trades at $34.92, up 1.42% over 24 hours, with a bullish technical signal driven by moving averages. The ETF has gained approximately 11% year-to-date, supported by Brazil's monetary easing cycle and commodity strength. Recent news highlights potential as a 2026 sleeper trade if rate cuts proceed, with exposure to Brazilian equities trading at a forward P/E of 9.6x as of Seeking Alpha on 2026-05-05.

Outlook is positive due to asymmetric upside from rate cuts, election repricing, and commodity tailwinds, but risks include Brazil's economic volatility and dependency on Petrobras/Vale dividends. Investors face currency and political uncertainties, though institutional interest remains with new positions like Altfest's $4.72 million investment in Q4 2025 per Defense World on 2026-04-12.